Integer Holdings (ITGR) Asset Writedowns and Impairment (2021 - 2024)

Integer Holdings (ITGR) posted Asset Writedowns and Impairment of $1.1 million for Q1 2024, up 78.98% sequentially from $590000.0 in Q4 2023.

Integer Holdings (ITGR) Asset Writedowns and Impairment (2021 - 2024) Analysis & Trends

Integer Holdings has reported Asset Writedowns and Impairment for 4 years, with the latest figure at $1.1 million in Q1 2024.

Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $1.1 million in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $1.1 million (up 78.98% YoY) and the FY2024 annual result came in at $1.1 million, up 78.98% from the prior year.
Asset Writedowns and Impairment advanced to $1.1 million in Q1 2024 per ITGR's latest filing, from $590000.0 in the prior quarter.
Over five years, Asset Writedowns and Impairment peaked at $1.1 million in Q1 2024 and troughed at $301000.0 in Q4 2021.
A 4-year average of $686250.0 and a median of $694000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.46 Bn	193.86 Bn	7.27 Bn
2	Stryker	127.41 Bn	123.93 Bn	4.50 Bn
3	Medtronic	118.87 Bn	109.65 Bn	6.41 Bn
4	Boston Scientific	73.47 Bn	72.93 Bn	3.85 Bn
5	Edwards Lifesciences	51.95 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.30 Bn	32.35 Bn	830.00 Mn
7	GE HealthCare Technologies	33.76 Bn	31.65 Bn	2.18 Bn
8	Koninklijke Philips	26.35 Bn	23.02 Bn	4.55 Bn
9	Steris	23.04 Bn	22.55 Bn	684.20 Mn
10	Integer Holdings	4.26 Bn	4.24 Bn	112.94 Mn

Download Data